Key Highlights AOD9604 activates lipolytic pathways through beta-3 adrenergic receptor upregulation and cAMP-PKA-HSL cascade activation in adipocytes The peptide inhibits acetyl-CoA carboxylase to suppress lipogenesis while promoting fatty acid oxidation in laboratory models Research confirms no IGF-1 stimulation or glucose metabolism disruption, distinguishing it from full-length growth hormone Cartilage studies show proteoglycan synthesis enhancement and improved tissue structure in osteoarthritis animal models What is AOD9604
Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al
Where are the new drugs? Across the largest Indian pharma companies, innovation is no longer a PowerPoint slide labeled optionality its showing up in revenue lines, regulatory approvals, and clinical milestones that would have been unthinkable a decade ago
Aside from using it to treat those who overdose on paracetamol (acetaminophen) and to break down mucus in the lungs, most doctors pay NAC little attention